Clinical TrialsSearch results
Number of results: 1050
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter phase II study of docetaxel and cisplatin as primary chemotherapy in patients with stage Ic-IV epithelial ovarian cancer
- Stage Ic-IV epithelial ovarian cancer
- A group for a study of DOC/CDDP combination chemotherapy for ovarian cancer
- 2006-12-18
Other
- Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
- Hematological malignancies
- A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.
- 2006-03-15
Recruiting
- Open-label, Phase 3 Study to Evaluate Efficacy and Safety of Odevixibat (A4250) in Patients with Alagille Syndrome
- Alagille Syndrome
- Achiwa Hiroyuki
- 2024-05-29
Recruiting
- A study in people with systemic sclerosis to test whether BI 685509 has an effect on lung function and other systemic sclerosis symptoms
- Progressive systemic sclerosis
- Adachi Sayaka
- 2022-10-21
Recruiting
- Investigational Randomized Controlled Trial of Patients with Chronic Thromboembolic Pulmonary Hypertension treated with Riociguat vs Selexipag
- chronic thromboembolic pulmonary hypertension
- Adachi Shiro
- 2021-12-26
Completed
- AML-12
- Acute Myeloid Leukemia
- Adachi Souichi
- 2019-03-26
Other
- Randomized Study to Assess the Efficacy of a Further 5 Years of Anastrozole Treatment for Postmenopausal Women with Breast Cancer Completing 5 Years Anastrozole Containing Adjuvant Endocrine Therapy
- Hormone-responsive postmenopausal primary breast cancer
- AERAS executive committee
- 2007-09-05
Recruiting
- Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Viral Lung Infection
- Ageishi Yuji
- 2023-02-08
Completed
- A Phase 2b Multicentre, Randomised, Double-Blind, Active-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety and Tolerability of Zibotentan and Dapagliflozin in Patients With Chronic Kidney Disease With Estimated Glomerular Filtration Rate (eGFR) Between 20 mL/Min/1.73 m^2 or more
- Chronic Kidney Disease
- Ageishi Yuji
- 2021-03-08
Other
- Phase I/II study of adoptive immunotherapy using cytotoxic T cells specific for minor histocompatibility antigen restricted to hematopoietic cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantation
- 1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CML
- Aichi Cancer Center
- 2005-09-12